R) v7.0 include the following: Abilify, Actonel, Advair, Aranesp,
Aricept, Avandia, Boniva, Botox, Caduet, Concerta, Crestor, Cymbalta,
Depakote, Depo- Provera, Detrol LA, Effexor XR, Enbrel, Flomax, Flonase,
Flovent, Fosamax, Gardasil, Glucophage XR, Humira, Humulin, Imitrex,
Lantus, Lexapro, Lipitor, Nasacort, Nasonex, Neulasta, Neurontin, Nexium,
Norvasc, NuvaRing, Ortho Tri- Cyclen Lo, Paxil, Plavix, Pravachol,
Prevacid, Protonix, Provigil, Pulmicort, Restasis, Risperdal, Rozerem,
Seasonale, Seroquel, Singulair, Strattera, Tamiflu, Topamax, Toprol XL,
Tricor, Valtrex, Vytorin, Yasmin, Yaz, Zocor, Zoloft, Zomig, Zyprexa and
Zyrtec.
Please visit http://www.manhattanresearch.com/ePC.htm to download the ePharma
Consumer(R) product brochure, request subscription information, and to
listen to two audio presentations summarizing highlights from the research.
Manhattan Research
ePharma Consumer(R) v7.0 is a syndicated multi-client study and
advisory service focused on key research topics and trends impacting online
U.S. consumers seeking pharmaceutical information. The study was fielded in
December 2007 among 5,112 U.S. adult consumers. In addition to ePharma
Consumer(R), Manhattan Research conducts five additional research studies
annually among consumers and physicians in the United States and in Europe:
Cybercitizen(R) Health US, Cybercitizen(R) Health Europe, Taking the
Pulse(R) US, Taking the Pulse(R) Europe, and ePharma Physician(R). Each
study serves a unique purpose and focuses on specific aspects of
information technology adoption. Broad consumer and physician research is
complemented by targeted analyses among more than 50 consumer therapeutic
segments and 25 physician specialist segments.
Contact:
Erica Alexander Martini
212-255-7799
Ealexander@Manhattanresearch.Com
'/>"/>SOURCE Manhattan Research Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs2.
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma3.
BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco4.
IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development5.
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price6.
eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th7.
The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience8.
Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer9.
Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation10.
Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases11.
Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year